3d
Zacks Investment Research on MSNEPD Expansion Supports Abbot Stock, Macro Issues PrevailAbbott's ABT diversified business portfolio is well-positioned to drive momentum. However, the international business ...
executive vice president of Abbott's diabetes care business. "But technology alone can't fix every barrier that people face. We're committed to doing our part, but we can't do it alone.
Overall, she said, the campaign is part of Abbott’s work to “chip away” at the obstacles facing people with diabetes as they seek out proper care and treatment. It builds on the stigma ...
We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...
Above the Bias, Abbott’s minute-long spot, seeks to address the shame, guilt and misconceptions that often surround diabetes. The short film also delves into how this bias can deter patients from ...
Abbott announced that it made its Lingo continuous glucose monitoring (CGM) system available for purchase on Amazon.
Abbott’s FreeStyle Libre blood glucose monitoring ... US where it would likely face stiff competition from existing diabetes care specialists, one of which is Livongo, which recently closed ...
Abbott had claimed that the shape of Sinocare ... “The judgments also reinforce the importance of consumer choice in diabetes care, ensuring that advanced CGM solutions remain accessible ...
In a report released today, Lee Hambright from Bernstein downgraded Tandem Diabetes Care (TNDM – Research Report) to a Hold, with a price ...
New survey shows 40% of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma 1 70% of people with diabetes said supportive comments from others can ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results